Sign In  |  Register  |  About Los Altos  |  Contact Us

Los Altos, CA
September 01, 2020 1:26pm
7-Day Forecast | Traffic

  • Search Hotels in Los Altos

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Tandem Diabetes Care (NQ: TNDM )

31.22 +1.18 (+3.93%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 27, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Tandem Diabetes Care

< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Tandem Diabetes Care: Q2 Earnings Insights
Tandem Diabetes Care (NASDAQ:TNDM) reported its Q2 earnings results on Wednesday, August 3, 2022 at 04:05 PM. Here's what investors need to know about the announcement. 
Via Benzinga
Tandem Diabetes Care Announces Second Quarter 2022 Financial Results and Updated Full Year 2022 Financial Guidance
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care Acquires Infusion Set Developer, Capillary Biomedical
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care to Announce Second Quarter 2022 Financial Results on August 3, 2022
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes' Q1 Bottom-Line Slide Deeper Into Red Despite Sales Growth
Via Benzinga
Earnings Scheduled For February 22, 2022
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is projected to report quarterly earnings at $0.13 per share on revenue of $439.63 million. • Sohu... 
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
  During Wednesday's session, 326 stocks hit new 52-week lows. 
Via Benzinga
Tandem Diabetes Care Welcomes Two New Members to Board of Directors
From Tandem Diabetes Care, Inc.
Via Business Wire
Stocks That Hit 52-Week Lows On Tuesday
On Tuesday, 951 companies hit new 52-week lows. 
Via Benzinga
Control-IQ Technology Continues to Demonstrate Positive and Sustained Real-World Benefits Across Diverse Cohorts of People with Diabetes
From Tandem Diabetes Care, Inc.
Via Business Wire
Dexcom Pops After Insulet Buyout Rumor Shakes Up Diabetes Stocks
The deal would have been transformative, but may have limited teamwork in the space. 
Via Investor's Business Daily
How The Rumored Dexcom-Insulet Marriage Could Rock The Entire Diabetes Space
One analyst called the rumored deal "transformative," but says the timing is unfavorable. 
Via Investor's Business Daily
Tandem Diabetes Care Announces Upcoming Virtual Conference Presentation
From Tandem Diabetes Care, Inc.
Via Business Wire
Stocks That Hit 52-Week Lows On Tuesday
On Tuesday, 540 companies set new 52-week lows. 
Via Benzinga
6 Analysts Have This to Say About Tandem Diabetes Care
Within the last quarter, Tandem Diabetes Care (NASDAQ:TNDM) has observed the following analyst ratings: 
Via Benzinga
83 Biggest Movers From Yesterday
Gainers Hudson Technologies, Inc. (NASDAQ: HDSN) shares jumped 26.9% to close at $9.06 on Thursday after the company reported better-than-expected Q1 EPS and sales results. 
Via Benzinga
57 Stocks Moving In Thursday's Mid-Day Session
Gainers 
Via Benzinga
Recap: Tandem Diabetes Care Q1 Earnings
Tandem Diabetes Care (NASDAQ:TNDM) reported its Q1 earnings results on Wednesday, May 4, 2022 at 04:05 PM. Here's what investors need to know about the announcement. 
Via Benzinga
Tandem Diabetes Care Announces First Quarter 2022 Financial Results and Updated Full Year 2022 Financial Guidance
From Tandem Diabetes Care, Inc.
Via Business Wire
Real-World Evidence Confirms Immediate and Ongoing Performance of the t:slim X2 Insulin Pump with Control-IQ Technology in Children and Adults
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care to Announce First Quarter 2022 Financial Results on May 4, 2022
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Reports Mixed Q4 Earnings, Issues Better Than Expected FY22 Outlook
Tandem Diabetes Care Inc (NASDAQ: TNDM) reported Q4 sales reached $209.9 million, +25% Y/Y, beating the consensus of $199.12 million. The Company posted EPS of $0.16,... 
Via Benzinga
Expert Ratings For Tandem Diabetes Care
Over the past 3 months, 4 analysts have published their opinion on Tandem Diabetes Care (NASDAQ:TNDM) stock. These analysts are typically employed by large Wall Street banks and... 
Via Benzinga
Tandem Diabetes Care: Q4 Earnings Insights
Tandem Diabetes Care (NASDAQ:TNDM) reported its Q4 earnings results on Tuesday, February 22, 2022 at 04:05 PM. Here's what investors need to know about the announcement.... 
Via Benzinga
Tandem Diabetes Care Announces Fourth Quarter and Full Year 2021 Financial Results and 2022 Financial Guidance
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care Announces FDA Clearance for the t:slim X2 Insulin Pump to Bolus Using the t:connect Mobile App
From Tandem Diabetes Care, Inc.
Via Business Wire
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
Biotech stock extended lower for a second straight week as risk aversion continued to pressure stocks amid geopolitical tensions and macroeconomic worries. On the regulatory front... 
Via Benzinga
Tandem Diabetes Care Announces Upcoming Virtual Conference Presentations
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care to Announce Fourth Quarter and Full Year 2021 Financial Results on February 22, 2022
From Tandem Diabetes Care, Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For January 19, 2022
Upgrades For Rocket Companies Inc (NYSE:RKT), JP Mo... 
Via Benzinga
< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 LosAltos.com & California Media Partners, LLC. All rights reserved.